Teva Pharmaceutical Industries Limited · TASE:TEVA
Lippman Evan sold 41,658 Teva Pharmaceutical Industries Limited shares (Form 4)
Traded May 14, 2026 · Filed May 18, 2026
On May 14, 2026, Lippman Evan (EVP, Business Development) sold 41,658 Teva Pharmaceutical Industries Limited shares at US$35.58 for US$1.48M under a trading plan, leaving 44,191 shares. Filed May 18, 2026 (Form 4).
- Sold
- 41,658 shares
- Price
- US$35.58
- Value
- US$1.48M
- Holding after
- 44,191 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Business Development
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 14, 2026 | Ordinary Shares | Option exercise | 11,841 | 11,841 | Direct | |
| May 14, 2026 | Ordinary Shares | Sale | 5,746 | US$35.58 | 6,095 | Direct |
| May 14, 2026 | Ordinary Shares | Option exercise | 74,008 | 80,103 | Direct | |
| May 14, 2026 | Ordinary Shares | Sale | 35,912 | US$35.58 | 44,191 | Direct |
Source
Related
- Teva Pharmaceutical Industries Limited
- Lippman Evan
- Teva Pharmaceutical Industries Limited shareholders
- Form 4 · Lippman Evan · Aug 19, 2026
- Form 4 · Savage Brian · Sep 22, 2026
- Form 4 · Mignone Roberto · Sep 22, 2026
- Form 4 · Weiss Amir · Aug 25, 2026
- Form 4 · Satchi-Fainaro Ronit · Aug 25, 2026
- Form 4 · Zaks Tal Zvi · Aug 10, 2026